Hans-Guenter Kaestle

Title: The Innovations of Hans-Guenter Kaestle

Introduction

Hans-Guenter Kaestle is a notable inventor based in Buggingen, Germany. He is recognized for his contributions to the pharmaceutical industry, particularly in the development of innovative drug formulations. His work has led to advancements that benefit both patients and healthcare providers.

Latest Patents

One of Hans-Guenter Kaestle's significant patents is a pharmaceutical composition comprising oseltamivir phosphate. This invention provides a formulation that includes one or more excipients selected from sugars and sugar alcohols, maintaining an equilibrium water content of 1% by weight or less at 25°C and 70% relative humidity. Additionally, the composition ensures that the amounts of glucose and mannose as impurities are 0.01% by weight or less. This patent highlights his expertise in creating effective pharmaceutical compositions.

Career Highlights

Throughout his career, Hans-Guenter Kaestle has worked with prominent companies in the pharmaceutical sector. Notably, he has been associated with Chugai Seiyaku Kabushiki Kaisha and F. Hoffmann-La Roche AG. His experience in these organizations has contributed to his knowledge and skills in drug development and formulation.

Collaborations

Hans-Guenter Kaestle has collaborated with several professionals in his field. Among his notable coworkers are Ryuji Kubota and Tomoaki Ohta. These collaborations have likely enriched his work and led to further innovations in pharmaceutical compositions.

Conclusion

Hans-Guenter Kaestle's contributions to the pharmaceutical industry, particularly through his patent on oseltamivir phosphate, demonstrate his commitment to innovation and improvement in drug formulations. His career reflects a dedication to advancing healthcare solutions.